- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
is a division of
World Vaccine Congress Washington 2009
Summary
20 Apr 2009-23 Apr 2009 — Washington Dulles, USA
Officially the longest-running and largest vaccine industry event in North America, World Vaccine
Congress continues to deliver a forum where the ever-changing dynamics of an industry in resurgence are discussed and acted upon by the industry's most senior figures.
Contact details
Gaurav Koul email: gaurav.koul@terrapinn.com phone: +44 (0)20 7092 1233
Booking
| Book early and save $889 |
Venue
Westfields Mariott, Washington Dulles, USA.
Congress — 20 Apr Mon-12:00 23 Apr 2009
Now in its 9th year, World Vaccine Congress 2009 remains the industry's definitive vaccine industry event for major vaccine players and their respective senior level representatives.
Over four days-the three day conference and investing in vaccines day- you can be confident that you will meet the World's most compelling and influential scientific and strategic leaders, facilitating education, debate and business.
Agenda
Investing in Vaccines Day - Monday 20 April 2009
- Governmental and Philanthropic Funding
- Corporate Venture Capital - Dividends "Beyond the Bottom Line"
- Navigating the Venture Path: The Quickest Route to Money
- Conference Day One - Tuesday 21 April 2009
- Vaccines: Who's Calling the Shots?
- Industry Injection - A Role for Pharma
- Global Health: Making Partnerships Work
Conference Day Two - Wednesday 22 April 2009
- Vaccine R&D: What's Over the Horizon?
- Redrawing the Vaccine Frontier
- Taking Aim at Novel Markets
- Influenza Evolution
- Regulatory Pathways to Approval
- Targetting Biodefense Markets
Conference Day Three - Thursday 23 April 2009
- R&D Growth Strategies
- Vaccine Clinical Trials and Tribulations
- Production, Manufacture and Capacity
- HIV Vaccines - Progress and Prospects
- Cancer Vaccines and Immunotherapy
- Adjuvants and Delivery Techniques
- Post Market Evaluation
For mor information or to register please visit the official website.
© Copyright 1995-2009 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us